157 related articles for article (PubMed ID: 2607778)
1. Prognostic implication of sequential bone marrow cultures in the myelodysplastic syndromes.
Yoshida Y; Yoshida C; Tohyama K; Ohmori S; Ohmori M; Ueda Y; Taniguchi Y; Uchino H
Leuk Res; 1989; 13(11):967-72. PubMed ID: 2607778
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic values of in vitro culture growth patterns of marrow granulocyte-macrophage progenitors in patients with myelodysplastic syndrome.
Shih LY; Chiu WF; Lee CT
Leukemia; 1991 Dec; 5(12):1092-8. PubMed ID: 1774958
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow in vitro growth and cytogenetic studies in patients with FAB-classified primary myelodysplastic syndromes.
Swolin B; Rödjer S; Westin J
Am J Hematol; 1990 Jul; 34(3):175-80. PubMed ID: 2363412
[TBL] [Abstract][Full Text] [Related]
4. [In-vitro change in CFU-GM in chronic myeloid leukemia and myelodysplastic syndromes. Its implication in the dysfunction of the hematologic barrier].
Gronda M; Malka A; Demattei A; Elizalde P; Santarelli MT; Bianchi de Di Risio CC
Sangre (Barc); 1988 Aug; 33(4):277-81. PubMed ID: 3187844
[No Abstract] [Full Text] [Related]
5. Bone marrow cultures in dysmyelopoietic syndrome: diagnostic and prognostic evaluation.
Shihab-el-Deen A; Guevara C; Prchal JF
Acta Haematol; 1987; 78(1):17-22. PubMed ID: 3116803
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow cultures and prognosis in primary myelodysplastic syndromes.
Korthout M; De Bock R; van Bockstaele D; Peetermans M
Leuk Res; 1990; 14(1):85-9. PubMed ID: 2304356
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood granulocyte-macrophage progenitors in patients with the myelodysplastic syndromes.
Tennant GB; Jacobs A; Bailey-Wood R
Exp Hematol; 1986 Dec; 14(11):1063-8. PubMed ID: 3780888
[TBL] [Abstract][Full Text] [Related]
8. Blast colony-forming cells in myelodysplastic syndrome: decreased potential to generate erythroid precursors.
Backx B; Broeders L; Touw I; Löwenberg B
Leukemia; 1993 Jan; 7(1):75-9. PubMed ID: 8418382
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous colony forming ability in vitro of the abnormal clone-derived granulocyte-macrophage precursors in myelodysplastic syndromes.
Okuda T; Yokota S; Maekawa T; Sonoda Y; Misawa S; Takino T; Abe T
Leuk Res; 1988; 12(8):687-92. PubMed ID: 3184986
[TBL] [Abstract][Full Text] [Related]
10. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro.
Maze R; Horie M; Hendrie P; Vadhan-Raj S; Tricot G; Gordon M; Nemunaitis J; Ashman LK; Broxmeyer HE
Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784
[TBL] [Abstract][Full Text] [Related]
11. Simple method for granulocyte-macrophage cell culture and staining in soft agar: comparison with a standard research technique.
Hyde K; Steed AJ; Lenehan H; Saunders MJ; Richards JT; Lin Yin JA; Geary CG
J Clin Pathol; 1989 Dec; 42(12):1302-8. PubMed ID: 2613925
[TBL] [Abstract][Full Text] [Related]
12. Ineffective hemopoiesis in the myelodysplastic syndromes (MDS) as studied by daily in situ observation of colony-cluster formation.
Ohmori M; Ohmori S; Ueda Y; Yoshida Y; Okuma M
Int J Cell Cloning; 1991 Sep; 9(5):521-30. PubMed ID: 1955740
[TBL] [Abstract][Full Text] [Related]
13. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
[TBL] [Abstract][Full Text] [Related]
14. Megakaryocyte, erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes.
Dan K; An E; Futaki M; Inokuchi K; Gomi S; Yamada T; Ogata K; Tanabe Y; Ohki I; Shinohara T
Acta Haematol; 1993; 89(3):113-8. PubMed ID: 8362599
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis, classification, and course of myelodysplastic syndromes.
McKenna RW; Allison PM
Clin Lab Med; 1990 Dec; 10(4):683-706. PubMed ID: 2272170
[TBL] [Abstract][Full Text] [Related]
16. In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic patients in response to recombinant human granulocyte-macrophage colony-stimulating factor.
Mayani H; Baines P; Bowen DT; Jacobs A
Leukemia; 1989 Jan; 3(1):29-32. PubMed ID: 2642575
[TBL] [Abstract][Full Text] [Related]
17. Myelodysplastic syndromes: preleukemic or early leukemic conditions?
Dörmer P
Haematol Blood Transfus; 1990; 33():3-7. PubMed ID: 2323634
[No Abstract] [Full Text] [Related]
18. Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haemopoietic growth factors.
Merchav S; Wagemaker G; Souza LM; Tatarsky I
Leukemia; 1991 Apr; 5(4):340-6. PubMed ID: 1709245
[TBL] [Abstract][Full Text] [Related]
19. Short-term liquid marrow cultures are supported by a mixture of haematopoietic cytokines but do not purge for acute myeloid or lymphoid leukemic marrow cells.
Johnsen HE; Gaarsdal E; Jensen L; Philip P; Hansen NE
Leukemia; 1993 Sep; 7(9):1402-8. PubMed ID: 8371591
[TBL] [Abstract][Full Text] [Related]
20. Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the Bournemouth score.
Oscier DG; Worsley A; Darlow S; Figes A; Williams JD; Hamblin TJ
Leuk Res; 1989; 13(9):833-9. PubMed ID: 2796388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
